---
figid: PMC4643087__jcav06p1306g005
figtitle: Ingenuity pathway analysis (IPA) revealed a key role for the Molecular Mechanisms
  of Cancer set of pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4643087
filename: jcav06p1306g005.jpg
figlink: /pmc/articles/PMC4643087/figure/F3/
number: F3
caption: 'Ingenuity pathway analysis (IPA) revealed a key role for the Molecular Mechanisms
  of Cancer set of pathways. We analyzed the subset of genes whose knockdown in TNBC
  cells treated with MEK inhibitor AS703026 led to no projections in the 3D MCTS system
  and were growth inhibition in the 2D monolayer system (5.1%). Molecular Mechanisms
  of Cancer was a top-ranking pathway. Output data indicated that PI3K pathway-related
  genes are the most important target molecules for combination with MEK inhibitor
  AS703026. Pink color indicated-gene: target gene from 2D/3D siRNA screening analysis.
  Blue color indicated-gene: negatively regulated downstream molecule by inhibition
  of pink color indicated-target molecule. Yellow color indicated-gene: possible mechanism
  on apoptosis by inhibition of target genes from 2D/3D siRNA screening. XL-147: a
  selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.'
papertitle: Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K
  Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of
  Triple-Negative Breast Cancer.
reftext: Jangsoon Lee, et al. J Cancer. 2015;6(12):1306-1319.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.85818
figid_alias: PMC4643087__F3
figtype: Figure
redirect_from: /figures/PMC4643087__F3
ndex: 46739793-dea2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4643087__jcav06p1306g005.html
  '@type': Dataset
  description: 'Ingenuity pathway analysis (IPA) revealed a key role for the Molecular
    Mechanisms of Cancer set of pathways. We analyzed the subset of genes whose knockdown
    in TNBC cells treated with MEK inhibitor AS703026 led to no projections in the
    3D MCTS system and were growth inhibition in the 2D monolayer system (5.1%). Molecular
    Mechanisms of Cancer was a top-ranking pathway. Output data indicated that PI3K
    pathway-related genes are the most important target molecules for combination
    with MEK inhibitor AS703026. Pink color indicated-gene: target gene from 2D/3D
    siRNA screening analysis. Blue color indicated-gene: negatively regulated downstream
    molecule by inhibition of pink color indicated-target molecule. Yellow color indicated-gene:
    possible mechanism on apoptosis by inhibition of target genes from 2D/3D siRNA
    screening. XL-147: a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pb
  - Pc
  - PCB
  - Tie
  - Ras85D
  - InR
  - Crk
  - .na.character
  - ras
  - Ras64B
  - Shc
  - drk
  - ATPsynbeta
  - Atpalpha
  - Epac
  - Fak
  - csw
  - Cbl
  - Sos
  - Nf1
  - Rap1
  - fzr
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - grp
  - Gagr
  - gpp
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Dsor1
  - Mtk
  - Rala
  - r-l
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - gre
  - MP1
  - Lamtor3
  - PDZ-GEF
  - garz
  - RhoGEF64C
  - pbl
  - rai
  - sgg
  - Erk7
  - rl
  - Dif
  - dl
  - Rel
  - Akt
  - Me
  - Raf
  - p53
  - betaTub60D
  - hth
  - na
  - bsk
  - foxo
  - cass
  - Debcl
  - pk
  - tefu
  - Jra
  - nbs
  - Mmp1
  - kay
  - Fs(3)Bak
  - Myc
  - Brca2
  - CycE
  - cyc
  - fo
  - Max
  - mof
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - MKP-4
  - p38b
  - dap
  - rb
  - ptc
  - Lamtor2
  - Arl1
  - Arf1
  - Arl2
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - cac
  - Lamtor1
  - MED21
  - dbo
  - Nxt1
  - ebi
  - E2f2
  - E2f1
  - Su(H)
  - CycC
  - osa
  - nej
  - DCTN6-p27
  - CG9588
  - Dark
  - Gli
  - ci
  - pan
  - Smox
  - Mad
  - Med
  - Tab2
  - Abd-B
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - tak
  - Tak1
  - Takl2
  - Su(fu)
  - Ask1
  - dsh
  - Fadd
  - Daxx
  - Pen
  - peng
  - peo
  - aph-1
  - Alp1
  - Acph-1
  - DCTN5-p25
  - smo
  - sm
  - SA
  - sa
  - dpp
  - gbb
  - wit
  - SMR3B
  - PC
  - CRK
  - CDK20
  - KRAS
  - HRAS
  - NRAS
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - GRB2
  - ATP8A2
  - RAPGEF3
  - RAPGEF4
  - A1BG
  - PTK2
  - PTPN11
  - CBL
  - IRS1
  - XYLT2
  - SOS1
  - SOS2
  - NF1
  - LRPAP1
  - CAMK4
  - CAMK2G
  - CAMK1
  - CAMK1D
  - CAMK1G
  - CAMK2A
  - CAMK2B
  - CAMK2D
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - GRP
  - LSM4
  - LGALSL
  - UCMA
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RALGDS
  - RALA
  - RALB
  - RASA1
  - RGS6
  - SYNGAP1
  - LAMTOR3
  - PITRM1
  - ARHGEF2
  - SLC2A4RG
  - GDF1
  - RNH1
  - PPP1R13L
  - GSK3A
  - GSK3B
  - EPHB2
  - MAPK1
  - MAPK3
  - NFKB1
  - MDM2
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TP53
  - TP63
  - TP73
  - MAPK8
  - MAPK9
  - MAPK10
  - BAD
  - BCL2
  - HIP1
  - ATM
  - PMAIP1
  - BID
  - JUN
  - JUNB
  - JUND
  - NBN
  - NLRP2
  - BBC3
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - FOS
  - BCL2L11
  - BAK1
  - MYC
  - BRCA1
  - BRCA2
  - BAX
  - FOSB
  - FOSL1
  - FOSL2
  - ZBTB17
  - PIAS2
  - MAX
  - CDKN2A
  - H3P10
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CYCS
  - PTCH1
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CDKN2C
  - UBE2I
  - MAFK
  - EEF1E1
  - ZNF197
  - ATRAID
  - LAMTOR1
  - TPPP2
  - H3P12
  - DIABLO
  - CDKN2B
  - MRPL28
  - NXT1
  - H3P9
  - MLIP
  - AK6
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - DHH
  - IHH
  - SHH
  - RBPJ
  - CCNC
  - EP300
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1B
  - CIB1
  - GLI1
  - LEF1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - RBL1
  - TAB1
  - TAB2
  - TAB3
  - APC
  - PROC
  - CDK9
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - SUFU
  - MAP3K5
  - ADAR
  - DVL1P1
  - FADD
  - DAXX
  - PUM3
  - PCSK1N
  - TSPAN33
  - APEH
  - NCSTN
  - MAT2B
  - TXNRD3
  - TBX1
  - CXCL11
  - SMO
  - SMOX
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CD2
  - FASLG
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - Breast cancer
  - Cancer
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
